ESPEN is a WHO project created in the spirit of a public-private partnership with the ultimate goal of accelerating the elimination of five PC-NTDs in Africa. Since its launch in May 2016, ESPEN works with domestic and international partners to leverage US$17.8 billion in drug donations from pharmaceutical companies to expand coverage and access to treatments, strengthen health systems and provide Universal health coverage of interventions against PC NTDs in Africa until we reach final elimination of these devastating diseases.
ESPEN’s goal will be achieved through the following four objectives:
- Scale up treatments towards the achievement of 100% geographical coverage
- Scale down: Stopping treatments once transmission has been interrupted or control achieved
- Strengthen information systems for evidence-based action
- Improve the effective use of donated medicines through enhancing supply chain management